LONDON (EGMN) - An antiviral agent normally used to treat an AIDS-associated complication could increase the sensitivity of cancers associated with human papillomaviruses to chemoradiotherapy, according to preliminary study findings.As reported at the European Society for Therapeutic Radiation Oncology Anniversary Conference, cidofovir appears to increase the sensitivity of locally advanced cervical carcinomas to the effects of radiotherapy and chemotherapy. It has resulted in no local failures or...